SunBio,Inc. (KOSDAQ:067370)

SunBio,Inc. Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2014	FY 2013
Period Ending	Dec 31, 2014	Dec 31, 2013
Revenue	2,171	2,122
Revenue Growth (YoY)	2.28%	-
Cost of Revenue	940.23	678.71
Gross Profit	1,231	1,444
Selling, General & Admin	778.26	673
Other Operating Expenses	65.99	164.19
Operating Expenses	881.34	836.15
Operating Income	349.26	607.5
Interest Expense	-22.71	-40.31
Interest & Investment Income	82.33	92.64
Currency Exchange Gain (Loss)	-0.05	69.95
Other Non Operating Income (Expenses)	1.96	0.16
EBT Excluding Unusual Items	410.79	729.94
Gain (Loss) on Sale of Investments	5.4	-
Gain (Loss) on Sale of Assets	1,088	-
Pretax Income	1,504	729.94
Income Tax Expense	109.82	81.98
Net Income	1,394	647.96
Net Income to Common	1,394	647.96
Net Income Growth	115.16%	-
Shares Outstanding (Basic)	6	6
Shares Outstanding (Diluted)	6	6
Shares Change (YoY)	0.10%	-
EPS (Basic)	249.33	116.00
EPS (Diluted)	249.33	116.00
EPS Growth	114.94%	-
Free Cash Flow	-868.06	769.8
Free Cash Flow Per Share	-155.24	137.81
Gross Margin	56.69%	68.02%
Operating Margin	16.09%	28.62%
Profit Margin	64.22%	30.53%
Free Cash Flow Margin	-39.99%	36.27%
EBITDA	403.98	698.02
EBITDA Margin	18.61%	32.89%
D&A For EBITDA	54.71	90.52
EBIT	349.26	607.5
EBIT Margin	16.09%	28.62%
Effective Tax Rate	7.30%	11.23%

Source: S&P Capital IQ. Standard template. Financial Sources.